synthetic biology
3 statements across 3 episodes · 1 bullish · 1 bearish · 2 people on the record · first statement Jan 18, 2022 by Ari Lipman · across every show →
Everything said about synthetic biology, oldest first
Jan 18, 2022 positive
Lipman: Synbio startups should prioritize niche, high-value markets
“You know, you always want to try to own a larger portion of a small market than try to own a small portion of a large market, at least at the outset. So I think, and that has been the tradition across the biotech industry and across synthetic biology is go for…”
May 12, 2022 bearish
Feb 2, 2023 neutral
Kann: Synbio chemical startups succeed in high-value, low-volume niches
“What we've seen so far is some companies having a lot of success producing sort of More complex chemicals that are higher value, but smaller volume commodities. So solugen would be the sort of classic example of this. This is a private venture backed company w…”